Biodesix's Series E - IV Round

Biodesix raised a round of funding on June 23, 2015.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Series E - IV Round: